A drug for sickle cell disease is showing great promise in the early stages of its clinical trial, a conference has heard.
The first findings from the trial of the drug IMR-687 were reported to the European Haematology Association Congress in Amst...
5 years ago
The NHS is seeking to be among the first health services in the world to adopt ‘tumour agnostic’ drugs, its Chief Executive Simon Stevens announced last week.
NHS England will seek to fast-track the introduction of these drugs once they gain licen...
5 years ago
